Clinical Trial Update: Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial comparing TransCon hGH weekly to daily hGH in Chinese pediatric growth hormone deficiency assesses safety, tolerability, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• TransCon hGH (somatropin)

Snippet

Sponsor: Visen Pharmaceuticals (Shanghai) Co., Ltd. | Conditions: Growth Hormone Deficiency, Endocrine System Diseases | Phase 3 | Status: UNKNOWN